IDEX (IEX) Q4 2008 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2008 earnings summary
9 Nov, 2026Executive summary
FY08 sales rose 10% to $1,489.5M, driven by acquisitions and currency; organic sales were flat. Net income fell 15% to $131.4M, with restructuring and goodwill impairment weighing on operating results.
International customers contributed 47% of sales; domestic organic sales declined 3%, while international organic sales increased 4%.
Financial highlights
Net sales were $1,489.5M, up 10% YoY; acquisitions added 9% and FX 1%, while organic sales were flat.
Gross profit rose 6% to $603.9M; reported gross margin declined 130 bps to 40.5%, reflecting mix, material costs and acquisitions.
Reported operating income fell 17% to $212.4M; it included $18.0M of restructuring expenses and a $30.1M goodwill impairment charge.
Net income was $131.4M, down 15%; diluted EPS was $1.60, down 15% YoY.
Outlook and guidance
Liquidity was expected to cover operations, interest, required debt repayments, authorized repurchases, planned capex and dividends for the next 12 months.
Additional acquisition financing could require long-term borrowing; availability on satisfactory terms was uncertain amid adverse financial and economic conditions.
Management expected international operations and export sales to continue contributing to earnings; no earnings forecast was stated.
Latest events from IDEX
- Margin gains and record cash generation offset weak base-business demand.IEX
Q4 2002 - Pump Products led FY2003 results as diversified industrial operations managed short backlogs and legal uncertainty.IEX
Q4 2003 - Pump Products led 2004 sales and income as acquisitions broadened the global portfolio.IEX
Q4 2004 - Organic growth accelerated to 10%, while international and acquisition risks remain material.IEX
Q4 2005 - Organic growth, acquisitions and Lean gains lifted sales and margins in 2006.IEX
Q4 2006 - Organic growth and higher gross margin lifted FY07 earnings as acquisition activity expanded the portfolio.IEX
Q4 2007 - Broad organic weakness cut FY09 sales 11%, while cash flow funded operations and investment.IEX
Q4 2009 - FY10 recovery lifted sales 14% and operating margin to 16.5%; FY11 EPS guided to $2.23–$2.33.IEX
Q4 2010 - FY11 sales climbed 22%; FY12 diluted EPS guidance was $2.74–$2.82.IEX
Q4 2011